Registration and Licensing

Cover of Motorised Mobility Devices: Stakeholder Feedback and Project Finalisation
Motorised Mobility Devices: Stakeholder Feedback and Project Finalisation
  • Publication no: AP-R622-20
  • ISBN: 978-1-922382-02-3
  • Published: 12 June 2020

This report collates stakeholder feedback provided in response to a Discussion Paper Motorised Mobility Devices Discussion Paper: Establishing a Nationally Consistent Framework and Adopting Technical Specification 3695.3.2018 circulated in August 2019.

Responses were received from a range of stakeholders, including motorised mobility device (MMD) user representative groups, government and industry representatives.

As a result, Austroads has become aware of a number of reviews that are underway or planned, which have the potential to impact the outcome of this project. It is therefore recommended that adoption of a technical specification for MMDs not be progressed due to the possible results from those other reviews.

Stakeholders expressed opposition to national registration and licensing arrangements for MMDs and their users. As a result, it is also recommended that no further action be taken with respect to registration and licensing schemes. Options for third party insurance are also explored.

  • Summary
  • 1. Background
    • 1.1 Technical Specification
    • 1.2 Related Projects
  • 2. Feedback Summary
    • 2.1 Complementary Policy Reviews
    • 2.2 Adoption of the Technical Specification
      • 2.2.1 Option 1 Do Nothing
      • 2.2.2 Option 2 Consumer Driven Adoption
      • 2.2.3 Option 3 Industry Driven Adoption
      • 2.2.4 Option 4 Regulatory Prescription
    • 2.3 Unladen Mass Limits
    • 2.4 Licensing and Registration
      • 2.4.1 Licensing for MMDs
      • 2.4.2 Registration for MMDs
    • 2.5 Third-Party Injury Insurance
    • 2.6 Comments out of Project Scope
      • 2.6.1 Details of the Technical Specification
      • 2.6.2 DSAPT Compliance
      • 2.6.3 Infrastructure Changes
      • 2.6.4 The Importation of Non-compliant Devices
      • 2.6.5 Therapeutic Goods Administration
  • 3. Recommendations and Next Steps
    • 3.1 Recommendations
    • 3.2 Next Steps
  • Appendix A Discussion Paper
    • A.1 Purpose of the Discussion Paper
    • A.2 Context
      • A.2.1 Current Regulation
      • A.2.2 Background
      • A.2.3 National Transport Commission Project
      • A.2.4 Senate Inquiry Recommendations
    • A.3 Adoption of The Technical Specification For MMDS
      • A.3.1 What is the Technical Specification for MMDs?
      • A.3.2 Unladen Mass Limit
      • A.3.3 Intended Safety Benefits
      • A.3.4 Certification
    • A.4 Options for Adoption of The Technical Specification
      • A.4.1 Option 1 – Do Nothing
      • A.4.2 Option 2 – Consumer Driven Adoption of the Technical Specification
      • A.4.3 Option 3 – Industry Driven Adoption of the Technical Specification
      • A.4.4 Option 4 – Regulatory Prescription of the Technical Specification
      • A.4.5 Other Regulatory Considerations
    • A.5 Recommended Approach for Adoption of The Technical Specification
    • A.6 Registration and Licensing for MMDs
      • A.6.1 Summary of Advantages Identified by the Senate Inquiry Submissions
      • A.6.2 Summary of Disadvantages Identified by the Senate Inquiry Submissions
      • A.6.3 Registration of MMDs
      • A.6.4 Recommended Approach for Registration of MMDs
      • A.6.5 Licensing of MMD Users
      • A.6.6 Recommended Approach for Licensing of MMDs
    • A.7 Guidance Questions for Response
    • A.8 Next Steps
    • A.9 Appendix
  • Appendix B Stakeholder List